000 01073 a2200349 4500
005 20250512072708.0
264 0 _c19870319
008 198703s 0 0 eng d
022 _a0008-5472
040 _aNLM
_beng
_cNLM
100 1 _aGrunberg, S M
245 0 0 _aPhase I study of recombinant beta-interferon given by four-hour infusion.
_h[electronic resource]
260 _bCancer research
_cFeb 1987
300 _a1174-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterferon Type I
_xadministration & dosage
650 0 4 _aInterferon beta-1a
650 0 4 _aInterferon beta-1b
650 0 4 _aInterferon-beta
650 0 4 _aKinetics
650 0 4 _aMale
650 0 4 _aRecombinant Proteins
_xadministration & dosage
650 0 4 _aTime Factors
700 1 _aKempf, R A
700 1 _aVenturi, C L
700 1 _aMitchell, M S
773 0 _tCancer research
_gvol. 47
_gno. 4
_gp. 1174-8
999 _c3807791
_d3807791